261 related articles for article (PubMed ID: 37997816)
1. Effects of gut microbiome and obesity on the development, progression and prevention of cancer (Review).
Kumavath R; Pavithran H; Paul S; Anju VT; Busi S; Dyavaiah M
Int J Oncol; 2024 Jan; 64(1):. PubMed ID: 37997816
[TBL] [Abstract][Full Text] [Related]
2. Microbiome and colorectal cancer: Roles in carcinogenesis and clinical potential.
Saus E; Iraola-Guzmán S; Willis JR; Brunet-Vega A; Gabaldón T
Mol Aspects Med; 2019 Oct; 69():93-106. PubMed ID: 31082399
[TBL] [Abstract][Full Text] [Related]
3. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
4. Microbiome Dysbiosis, Dietary Intake and Lifestyle-Associated Factors Involve in Epigenetic Modulations in Colorectal Cancer: A Narrative Review.
Kwao-Zigah G; Bediako-Bowan A; Boateng PA; Aryee GK; Abbang SM; Atampugbire G; Quaye O; Tagoe EA
Cancer Control; 2024; 31():10732748241263650. PubMed ID: 38889965
[No Abstract] [Full Text] [Related]
5. Gut microbiota imbalance and colorectal cancer.
Gagnière J; Raisch J; Veziant J; Barnich N; Bonnet R; Buc E; Bringer MA; Pezet D; Bonnet M
World J Gastroenterol; 2016 Jan; 22(2):501-18. PubMed ID: 26811603
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiome in tumorigenesis and therapy of colorectal cancer.
Wang L; Yu KC; Hou YQ; Guo M; Yao F; Chen ZX
J Cell Physiol; 2023 Jan; 238(1):94-108. PubMed ID: 36409765
[TBL] [Abstract][Full Text] [Related]
7. The Pivotal Role of the Gut Microbiome in Colorectal Cancer.
Siddiqui R; Boghossian A; Alharbi AM; Alfahemi H; Khan NA
Biology (Basel); 2022 Nov; 11(11):. PubMed ID: 36358343
[TBL] [Abstract][Full Text] [Related]
8. Gut Microbiota Dysbiosis Drives the Development of Colorectal Cancer.
Fan X; Jin Y; Chen G; Ma X; Zhang L
Digestion; 2021; 102(4):508-515. PubMed ID: 32932258
[TBL] [Abstract][Full Text] [Related]
9. Gut Microbiome in Colorectal Cancer: Clinical Diagnosis and Treatment.
Liu Y; Lau HC; Cheng WY; Yu J
Genomics Proteomics Bioinformatics; 2023 Feb; 21(1):84-96. PubMed ID: 35914737
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiome: decision-makers in the microenvironment of colorectal cancer.
Han J; Zhang B; Zhang Y; Yin T; Cui Y; Liu J; Yang Y; Song H; Shang D
Front Cell Infect Microbiol; 2023; 13():1299977. PubMed ID: 38156313
[TBL] [Abstract][Full Text] [Related]
11. Environmental Factors, Gut Microbiota, and Colorectal Cancer Prevention.
Song M; Chan AT
Clin Gastroenterol Hepatol; 2019 Jan; 17(2):275-289. PubMed ID: 30031175
[TBL] [Abstract][Full Text] [Related]
12. Gut Dysbiosis and Intestinal Barrier Dysfunction: Potential Explanation for Early-Onset Colorectal Cancer.
Ahmad Kendong SM; Raja Ali RA; Nawawi KNM; Ahmad HF; Mokhtar NM
Front Cell Infect Microbiol; 2021; 11():744606. PubMed ID: 34966694
[TBL] [Abstract][Full Text] [Related]
13. Altered gut microbiota in hepatocellular carcinoma: Insights into the pathogenic mechanism and preclinical to clinical findings.
Das BK
APMIS; 2022 Dec; 130(12):719-740. PubMed ID: 36321381
[TBL] [Abstract][Full Text] [Related]
14. Interplay between Dysbiosis of Gut Microbiome, Lipid Metabolism, and Tumorigenesis: Can Gut Dysbiosis Stand as a Prognostic Marker in Cancer?
Chattopadhyay I; Gundamaraju R; Jha NK; Gupta PK; Dey A; Mandal CC; Ford BM
Dis Markers; 2022; 2022():2941248. PubMed ID: 35178126
[TBL] [Abstract][Full Text] [Related]
15. Implication of Obesity and Gut Microbiome Dysbiosis in the Etiology of Colorectal Cancer.
Singh S; Sharma P; Sarma DK; Kumawat M; Tiwari R; Verma V; Nagpal R; Kumar M
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980799
[TBL] [Abstract][Full Text] [Related]
16. Design of the Building Research in CRC prevention (BRIDGE-CRC) trial: a 6-month, parallel group Mediterranean diet and weight loss randomized controlled lifestyle intervention targeting the bile acid-gut microbiome axis to reduce colorectal cancer risk among African American/Black adults with obesity.
McLeod A; Wolf P; Chapkin RS; Davidson LA; Ivanov I; Berbaum M; Williams LR; Gaskins HR; Ridlon J; Sanchez-Flack J; Blumstein L; Schiffer L; Hamm A; Cares K; Antonic M; Bernabe BP; Fitzgibbon M; Tussing-Humphreys L
Trials; 2023 Feb; 24(1):113. PubMed ID: 36793105
[TBL] [Abstract][Full Text] [Related]
17. Adjusting for age improves identification of gut microbiome alterations in multiple diseases.
Ghosh TS; Das M; Jeffery IB; O'Toole PW
Elife; 2020 Mar; 9():. PubMed ID: 32159510
[TBL] [Abstract][Full Text] [Related]
18. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders: Current Evidence and Perspectives.
Vallianou N; Stratigou T; Christodoulatos GS; Dalamaga M
Curr Obes Rep; 2019 Sep; 8(3):317-332. PubMed ID: 31175629
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiota, inflammatory bowel disease and colorectal cancer.
Quaglio AEV; Grillo TG; De Oliveira ECS; Di Stasi LC; Sassaki LY
World J Gastroenterol; 2022 Aug; 28(30):4053-4060. PubMed ID: 36157114
[TBL] [Abstract][Full Text] [Related]
20. The Gut Microbiome and Hepatocellular Carcinoma.
Akkız H
J Gastrointest Cancer; 2021 Dec; 52(4):1314-1319. PubMed ID: 34870783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
